Does prime modality influence morphological processing?

Brain Lang

University at Albany, State University of New York, 1400 Washington Avenue, Albany, NY 12222, USA.

Published: July 2002

Facilitation among morphologically related words generally is impervious to the prefixed or suffixed structure of primes and targets. A notable exception arises, however, when both primes and targets are suffixed. More specifically, when primes are auditory and targets are visual, facilitation for a suffixed target (e.g., payment) is absent when it follows a prime (e.g., payable) that is morphologically related and suffixed (Marslen-Wilson, Tyler, Waksler, & Older, 1994). To account for null facilitation (viz., the "suffix-suffix" effect), Marslen-Wilson and his colleagues posit inhibitory links between suffixes of morphological relatives. The present study assesses the generality of the "suffix-suffix" effect. When morphological facilitation is assessed relative to an orthographically related baseline, suffixed primes facilitate derivationally as well as inflectionally related morphological targets when primes are visual as well as auditory in both the lexical decision and naming tasks. The present findings call into question lexical models that posit inhibitory links between suffixes of morphological relatives.

Download full-text PDF

Source
http://dx.doi.org/10.1006/brln.2001.2504DOI Listing

Publication Analysis

Top Keywords

primes targets
8
suffixed primes
8
posit inhibitory
8
inhibitory links
8
links suffixes
8
suffixes morphological
8
morphological relatives
8
morphological
5
suffixed
5
primes
5

Similar Publications

Background: Improved diagnostic testing (DT) of infections may optimize outcomes for solid organ transplant recipients (SOTR), but a comprehensive analysis is lacking.

Methods: We conducted a systematic literature review across multiple databases, including EMBASE and MEDLINE(R), of studies published between 1 January 2012-11 June 2022, to examine the evidence behind DT in SOTR. Eligibility criteria included the use of conventional diagnostic methods (culture, biomarkers, directed-polymerase chain reaction [PCR]) or advanced molecular diagnostics (broad-range PCR, metagenomics) to diagnose infections in hospitalized SOTR.

View Article and Find Full Text PDF

NLRX1 limits inflammatory neurodegeneration in the anterior visual pathway.

J Neuroinflammation

January 2025

Department of Neurology, Division of Neuroimmunology, School of Medicine, Johns Hopkins University, Baltimore, MD, 21287, USA.

Chronic innate immune activation in the central nervous system (CNS) significantly contributes to neurodegeneration in progressive multiple sclerosis (MS). Using multiple experimental autoimmune encephalomyelitis (EAE) models, we discovered that NLRX1 protects neurons in the anterior visual pathway from inflammatory neurodegeneration. We quantified retinal ganglion cell (RGC) density and optic nerve axonal degeneration, gliosis, and T-cell infiltration in Nlrx1 and wild-type (WT) EAE mice and found increased RGC loss and axonal injury in Nlrx1 mice compared to WT mice in both active immunization EAE and spontaneous opticospinal encephalomyelitis (OSE) models.

View Article and Find Full Text PDF

Background: CheckMate 8HW prespecified dual primary endpoints, assessed in patients with centrally confirmed microsatellite instability-high or mismatch repair-deficient status: progression-free survival with nivolumab plus ipilimumab compared with chemotherapy as first-line therapy and progression-free survival with nivolumab plus ipilimumab compared with nivolumab alone, regardless of previous systemic treatment for metastatic disease. In our previous report, nivolumab plus ipilimumab showed superior progression-free survival versus chemotherapy in first-line microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer in the CheckMate 8HW trial. Here, we report results from the prespecified interim analysis for the other primary endpoint of progression-free survival for nivolumab plus ipilimumab versus nivolumab across all treatment lines.

View Article and Find Full Text PDF

Cancer is one of the leading causes of death worldwide. In recent years, immune checkpoint inhibitor therapies, in addition to standard immuno- or chemotherapy and surgical approaches, have massively improved the outcome for cancer patients. However, these therapies have their limitations and improved strategies, including access to reliable cancer vaccines, are needed.

View Article and Find Full Text PDF

Protocol to Retrieve Unknown Flanking DNA Using Fork PCR for Genome Walking.

Bio Protoc

January 2025

International Institute of Food Innovation Co., Ltd., Nanchang University, Nanchang, China.

PCR-based genome walking is one of the prevalent techniques implemented to acquire unknown flanking genomic DNAs. The worth of genome walking includes but is not limited to cloning full-length genes, mining new genes, and discovering regulatory regions of genes. Therefore, this technique has advanced molecular biology and related fields.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!